Trilio-Medical

Developer of a medical device designed to offer a novel tricuspid-regurgitation repair and delivery system.

Health Tech & Life Sciences
Active
Seed Or Yehuda, Israel Founded 2022
Last updated 2026-07-26
Total raised
$2.1M
Last: Undisclosed Round 2022-11
Stage
Seed
Founded
2022
Headcount
2
HQ
Or Yehuda, Israel
Sector
Health Tech & Life Sciences

About

Trilio-Medical is redefining the standard of care for patients suffering from tricuspid regurgitation (TR). Their mission is to treat the untreatable and propose a superior Transcatheter Tricuspid Valve Intervention (TTVI) solution. They aim to simplify transcatheter tricuspid repair with an intuitive, easy-to-use system designed for fast adoption and consistent results. Their novel implant provides full coverage of both central and eccentric tricuspid regurgitation, ensuring effective treatment across a wide range of anatomies. The anatomy-preserving structure was designed to maintain native leaflet integrity, reducing procedural complexity and risk. Their system is fully repositionable and retrievable, offering physicians greater control and safety during the procedure.

Funding history · 1 round · $2.1M total

2022-10
Seed $2.1M
★ MEDX Xelerator

Headcount over time

From 1 (2022-11) to 1 (2025-12) · +0 (+0%) · 3 points · source: Finder history + radar grounding
20 2022-11 2025-12

Q&A

What is Trilio-Medical's primary focus?
Trilio-Medical is a developer of a medical device designed to offer a novel tricuspid-regurgitation repair and delivery system, aiming to redefine the standard of care for patients suffering from tricuspid regurgitation (TR).
When was Trilio-Medical founded?
Trilio-Medical was founded in 2022.
Where is Trilio-Medical headquartered?
Trilio-Medical is headquartered in Or Yehuda, Israel.
How much funding has Trilio-Medical raised to date?
Trilio-Medical has raised a total of $2.1 million USD.
Which investors participated in Trilio-Medical's Seed round?
In November 2022, Trilio-Medical raised a Seed round with participation from MEDX Xelerator.
What is the employee count for Trilio-Medical?
Trilio-Medical has an employee count in the 1-10 range.
Who is the Founder & CEO of Trilio-Medical?
Yuval Raz is the Founder & CEO of Trilio-Medical.
What are the key features of Trilio-Medical's novel implant?
Trilio-Medical's novel implant provides full coverage of both central and eccentric tricuspid regurgitation, maintains native leaflet integrity, and is fully repositionable and retrievable.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

valvesmedical-devicescardiology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitewww.trilio-medical.com
LinkedInlinkedin.com/company/87381770

Identifiers & details

Former namesTRILIO
Founded2022
Employees (exact)2

Radar intelligence

Patents

EPO1

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516684909
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2022-09-21
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events1 — annual_report (1)
Registered addressשרון אריאל 8 אור יהודה

Recent registry events

DateEvent
2025-07-21דו~ח שנתי